Skip to main content
OpenTrials

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

392 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Macular Degeneration trial results

Completed

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease

NCT05244304

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations
  • Belite Study Site Palo Alto, California, United States
  • Belite Study Site Minneapolis, Minnesota, United States
  • Belite Study Site Salt Lake City, Utah, United States
  • Belite Study Site Westmead, New South Wales, Australia
View all 19 locations
View Trial Details
Completed

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

NCT03364153

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations
  • Retinal Research Institute Phoenix, Arizona, United States
  • Jules Stein Eye Institute/ David Geffen School of Medicine Los Angeles, California, United States
  • VitreoRetinal Associates Gainesville, Florida, United States
  • Retina Specialty Institute Pensacola, Florida, United States
View all 41 locations
View Trial Details
Completed

Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.

NCT05959304

Conditions
Diabetic Macular Edema, Eye Diseases, Macular Degeneration, +9 more
Locations
  • Novartis Investigative Site Ahmedabad, Gujarat, India
  • Novartis Investigative Site Bangalore, Karnataka, India
  • Novartis Investigative Site Kochi, Kerala, India
  • Novartis Investigative Site Chennai, Tamil Nadu, India
View Trial Details
Completed

A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

NCT05520177

Conditions
Branch Retinal Vein Occlusion, Cardiovascular Diseases, Embolism and Thrombosis, +9 more
Locations
  • BeiJing Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of JiNan University Guangzhou, Guangdong, China
  • HeNan Provincial Eye Hospital Zhengzhou, Henan, China
  • The Second XiangYa Hospital of Central South University Changsha, Hunan, China
View Trial Details
Completed

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

NCT06011798

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +18 more
Locations
  • California Retina Consultants Bakersfield, California, United States
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Salehi Retina Institute Inc. Huntington Beach, California, United States
  • Bay Area Retina Associates Walnut Creek, California, United States
View all 19 locations
View Trial Details

Related conditions